SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-038103
Filing Date
2012-07-03
Accepted
2012-07-03 16:42:03
Documents
9
Period of Report
2012-06-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v317745_8k.htm 8-K 17986
2 EXHIBIT 99.1 v317745_ex99-1.htm EX-99.1 1060
3 GRAPHIC v317745_ex99-1x1x1.jpg GRAPHIC 97250
4 GRAPHIC v317745_ex99-1x2x1.jpg GRAPHIC 148183
5 GRAPHIC v317745_ex99-1x3x1.jpg GRAPHIC 137731
6 GRAPHIC v317745_ex99-1x4x1.jpg GRAPHIC 141769
7 GRAPHIC v317745_ex99-1x5x1.jpg GRAPHIC 134986
8 GRAPHIC v317745_ex99-1x6x1.jpg GRAPHIC 128202
9 GRAPHIC v317745_ex99-1x7x1.jpg GRAPHIC 55433
  Complete submission text file 0001144204-12-038103.txt   1183447
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 8-K | Act: 34 | File No.: 000-53963 | Film No.: 12945623
SIC: 2835 In Vitro & In Vivo Diagnostic Substances